[go: up one dir, main page]

MA26693A1 - Compositions pour administration par voie buccale - Google Patents

Compositions pour administration par voie buccale

Info

Publication number
MA26693A1
MA26693A1 MA25782A MA25782A MA26693A1 MA 26693 A1 MA26693 A1 MA 26693A1 MA 25782 A MA25782 A MA 25782A MA 25782 A MA25782 A MA 25782A MA 26693 A1 MA26693 A1 MA 26693A1
Authority
MA
Morocco
Prior art keywords
compositions
oral administration
oral
administration
Prior art date
Application number
MA25782A
Other languages
English (en)
Inventor
Bruce Balik Samuel
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of MA26693A1 publication Critical patent/MA26693A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Psychology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA25782A 1998-09-28 1999-09-23 Compositions pour administration par voie buccale MA26693A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10211298P 1998-09-28 1998-09-28

Publications (1)

Publication Number Publication Date
MA26693A1 true MA26693A1 (fr) 2004-12-20

Family

ID=22288187

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25782A MA26693A1 (fr) 1998-09-28 1999-09-23 Compositions pour administration par voie buccale

Country Status (17)

Country Link
EP (1) EP1117407A1 (fr)
JP (1) JP2002525328A (fr)
KR (1) KR20010075385A (fr)
CN (1) CN1328459A (fr)
AR (1) AR022673A1 (fr)
AU (1) AU6087399A (fr)
BR (1) BR9914096A (fr)
CA (1) CA2345638A1 (fr)
CZ (1) CZ20011142A3 (fr)
HU (1) HUP0103459A2 (fr)
IL (1) IL142054A0 (fr)
MA (1) MA26693A1 (fr)
NO (1) NO20011555L (fr)
PE (1) PE20001087A1 (fr)
PL (1) PL346877A1 (fr)
TR (1) TR200100863T2 (fr)
WO (1) WO2000018406A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001026641A2 (fr) * 1999-10-13 2001-04-19 Glaxo Group Limited Methode destinee au traitement de l'obesite
DE102008047910A1 (de) 2008-09-19 2010-03-25 Molkerei Meggle Wasserburg Gmbh & Co. Kg Tablettierhilfsstoff auf Laktose- und Cellulosebasis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4597969A (en) * 1982-04-05 1986-07-01 Merck Sharp & Dohme Stabilization of unstable drugs or food supplements
GB8924528D0 (en) * 1989-10-31 1989-12-20 Wellcome Found Heterocyclic pharmaceutical compounds,preparation and use

Also Published As

Publication number Publication date
JP2002525328A (ja) 2002-08-13
NO20011555D0 (no) 2001-03-27
PE20001087A1 (es) 2000-10-20
CA2345638A1 (fr) 2000-04-06
BR9914096A (pt) 2001-07-31
AU6087399A (en) 2000-04-17
AR022673A1 (es) 2002-09-04
TR200100863T2 (tr) 2001-07-23
CZ20011142A3 (cs) 2001-09-12
EP1117407A1 (fr) 2001-07-25
IL142054A0 (en) 2002-03-10
CN1328459A (zh) 2001-12-26
KR20010075385A (ko) 2001-08-09
WO2000018406A1 (fr) 2000-04-06
HUP0103459A2 (hu) 2002-01-28
NO20011555L (no) 2001-03-27
PL346877A1 (en) 2002-03-11

Similar Documents

Publication Publication Date Title
FR08C0004I2 (fr) Composition orale d' une dose pour une libération prolongée
NO20020208D0 (no) Flytende sammensetninger for oral administrasjon
MA26621A1 (fr) Composition pour aerosols pharmaceutiques
EA199900373A3 (ru) Фармацевтические композиции
FR2775596B1 (fr) Nouvelles compositions pharmaceutiques
PT1242087E (pt) Composicoes farmaceuticas
DK1140109T3 (da) Trefaset oralt antikonceptionsmiddel
ID27415A (id) Komposisi farmaseutik
NO20015175D0 (no) Farmasöytisk sammensetning
ID26720A (id) Komposisi oral
DE69822172D1 (de) Levosimendanhaltige oral anzuwendende arzneizusammensetzungen
ID29262A (id) Komposisi farmasi
ITMI982222A0 (it) Composizioni farmaceutiche orali contenenti buprenorfina
NO20020760L (no) Farmasöytiske sammensetninger for oral og topisk administrasjon
PT1239832E (pt) Composicoes farmaceuticas
NO996044L (no) Rapamycinformuleringer for oral administrasjon
PT102384A (pt) Composicoes farmaceuticas compreendendo metanossulfonato de paroxentina
FR2779145B1 (fr) Nouvelles compositions pharmaceutiques
EE200100281A (et) Analgeetiline ravimkoostis
FR2751534B1 (fr) Composition pour ameliorer l'hygiene buccale
MA26693A1 (fr) Compositions pour administration par voie buccale
IL149422A0 (en) Oral pharmaceutical compositions for liver therapy
HK1044117B (zh) 藥物組合物
IS2200B (is) Lyfjasamsetningar
FI981567A0 (fi) Farmaseuttiset koostumukset